Galera Therapeutics, Inc.
GRTXDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563577
Galera Therapeutics, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Aug 5, 2026; 36 institutions reported holding it in 13F filings for Q1 2024, worth $1.37M in total; no superinvestor held it.
Holders of 5% or more of GRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Galera Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Emerald Bioventures, LLC | 13D/A | 30.20%61.0M shares | +3.70 ppfrom 26.50% | Apr 27, 20262 filings | May 29, 2026 | SEC |
| Ikarian Capital, LLC | 13G | 9.99%7.54M shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Hyare Parvinder Singh | 13D | 6.65%13.5M shares | New | Jun 11, 20261 filing | Jun 11, 2026 | SEC |
| Chang Nancy T | 13D | 5.90%8.92M shares | New | Apr 10, 20261 filing | Apr 10, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Galera Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 20265:30 PM ET | Hyare Parvinder Singh | 13D | 6.65%13.5M shares | New | May 15, 2026 | SEC |
| May 29, 20264:58 PM ET | Emerald Bioventures, LLCand 1 other | 13D/A | 30.20%61.0M shares | +3.70 ppfrom 26.50% | May 15, 2026 | SEC |
| Apr 27, 20264:14 PM ET | Emerald Bioventures, LLCand 1 other | 13D | 26.50%40.2M shares | New | Apr 7, 2026 | SEC |
| Apr 10, 202612:29 PM ET | Chang Nancy T | 13D | 5.90%8.92M shares | New | Dec 30, 2024 | SEC |
| Feb 14, 20251:22 PM ET | Ikarian Capital, LLCand 1 other | 13G | 9.99%7.54M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Galera Therapeutics, Inc. shares.
No Form 144 notices for Galera Therapeutics, Inc. are on file.